Get the Stockscreener App
2.15
0.92%
-0.02
After Hours:
2.08
-0.07
-3.26%
Ensysce Biosciences Inc stock is traded at $2.15, with a volume of 63,244.
It is down -0.92% in the last 24 hours and up +0.00% over the past month.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
See More
Previous Close:
$2.17
Open:
$2.2
24h Volume:
63,244
Relative Volume:
0.17
Market Cap:
$6.38M
Revenue:
-
Net Income/Loss:
$-11.28M
P/E Ratio:
-0.7143
EPS:
-3.01
Net Cash Flow:
$-9.78M
1W Performance:
+2.38%
1M Performance:
+0.00%
6M Performance:
-60.26%
1Y Performance:
-61.67%
1-Day Range:
$2.10
$2.213
1-Week Range:
$2.0301
$2.213
52-Week Range:
$1.62
$14.67
Ensysce Biosciences Inc Stock (ENSC) Company Profile
Name
Ensysce Biosciences Inc
Sector
Industry
Phone
(858) 263-4196
Address
7946 IVANHOE AVENUE, LA JOLLA
Compare ENSC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENSC
Ensysce Biosciences Inc
|
2.15 | 6.17M | 0 | -11.28M | -9.78M | -3.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Ensysce Biosciences Inc Stock (ENSC) Latest News
Can Ensysce Biosciences Inc. keep up with sector leadersJuly 2025 Intraday Action & Expert Approved Momentum Ideas - khodrobank.com
Using RSI to spot recovery in Ensysce Biosciences Inc.Layoff News & Expert Approved Momentum Trade Ideas - Newser
Ensysce Biosciences Showcases Urgent Need for Safer Opioids at PAINWeek 2025 Symposium - 富途牛牛
Analyzing recovery setups for Ensysce Biosciences Inc. investorsShare Buyback & AI Powered Market Entry Ideas - Newser
Will Ensysce Biosciences Inc. stock recover after recent drop2025 Year in Review & Reliable Volume Spike Trade Alerts - Newser
Aug Patterns: Can Ensysce Biosciences Inc. continue delivering strong returnsEarnings Beat & Real-Time Buy Signal Alerts - khodrobank.com
Visualizing Ensysce Biosciences Inc. stock with heatmaps2025 Valuation Update & Safe Capital Growth Stock Tips - Newser
Can volume confirm reversal in Ensysce Biosciences Inc.July 2025 Levels & Reliable Momentum Entry Alerts - Newser
Intraday pattern recognizer results for Ensysce Biosciences Inc.2025 Key Highlights & Consistent Return Investment Signals - Newser
Using economic indicators to assess Ensysce Biosciences Inc. potentialTrade Risk Report & Weekly Top Gainers Trade List - Newser
Short interest data insights for Ensysce Biosciences Inc.Quarterly Profit Report & Long-Term Investment Growth Plans - Newser
Is Ensysce Biosciences Inc. stock trending bullishJuly 2025 Summary & Growth Focused Entry Point Reports - khodrobank.com
Applying Wyckoff theory to Ensysce Biosciences Inc. stockJuly 2025 Sentiment & Fast Moving Stock Watchlists - Newser
Can a trend reversal in Ensysce Biosciences Inc. lead to recoveryEarnings Growth Summary & Entry and Exit Point Strategies - Newser
Analyzing Ensysce Biosciences Inc. with risk reward ratio chartsJuly 2025 Technicals & Free Long-Term Investment Growth Plans - Newser
Pattern recognition hints at Ensysce Biosciences Inc. upside2025 Trading Recap & Fast Gaining Stock Strategy Reports - Newser
Long term hold vs stop loss in Ensysce Biosciences Inc.2025 Valuation Update & Real-Time Stock Movement Alerts - Newser
Risk vs reward if holding onto Ensysce Biosciences Inc.Stock Surge & AI Based Buy and Sell Signals - Newser
How to read the order book for Ensysce Biosciences Inc.CPI Data & Stock Market Timing Techniques - Newser
Analyzing drawdowns of Ensysce Biosciences Inc. with statistical toolsCPI Data & Weekly Breakout Watchlists - Newser
Forecasting Ensysce Biosciences Inc. price range with options dataShort Setup & Daily Risk Controlled Trade Plans - Newser
Is now a turning point for Ensysce Biosciences Inc.July 2025 Gainers & Community Supported Trade Ideas - Newser
Is Ensysce Biosciences Inc. trending in predictive chart models2025 Dividend Review & Verified Entry Point Signals - Newser
Live market analysis of Ensysce Biosciences Inc.Weekly Stock Recap & High Accuracy Trade Alerts - Newser
Chart based analysis of Ensysce Biosciences Inc. trendsJuly 2025 Trade Ideas & Community Verified Trade Alerts - Newser
What earnings revisions data tells us about Ensysce Biosciences Inc.Weekly Loss Report & Risk Adjusted Swing Trade Ideas - Newser
Will Ensysce Biosciences Inc. outperform its industry peersWeekly Investment Report & Expert Verified Movement Alerts - khodrobank.com
Should you hold or exit Ensysce Biosciences Inc. nowJuly 2025 Opening Moves & Consistent Income Trade Ideas - Newser
Ensysce Biosciences Inc. stock chart pattern explainedJuly 2025 Opening Moves & Stock Market Timing Techniques - Newser
What is Ensysce Biosciences Inc.’s TAM (Total Addressable Market)2025 Winners & Losers & Free Reliable Trade Execution Plans - khodrobank.com
What is the target price for Ensysce Biosciences Inc. stockJuly 2025 Market Mood & Daily Profit Maximizing Trade Tips - khodrobank.com
Chart overlay techniques for tracking Ensysce Biosciences Inc.Fed Meeting & Technical Confirmation Alerts - Newser
AI Indicators Detect Buy Opportunity in Ensysce Biosciences Inc. getLinesFromResByArray error: size == 0 - 강소기업뉴스
Price Consolidation Hints at Upcoming Move in Ensysce Biosciences Inc.Quarterly Profit Review & Advanced Swing Trade Entry Plans - beatles.ru
Automated trading signals detected on Ensysce Biosciences Inc.July 2025 Outlook & Scalable Portfolio Growth Methods - Newser
How to interpret RSI for Ensysce Biosciences Inc. stock2025 EndofYear Setup & Intraday High Probability Alerts - Newser
Ensysce Biosciences Inc. At Critical Juncture — Bounce or Breakdown getLinesFromResByArray error: size == 0 - 강소기업뉴스
Ensysce Biosciences Inc. Approaches Support With Recovery in Sight2025 Year in Review & Capital Protection Trade Alerts - beatles.ru
Identifying reversal signals in Ensysce Biosciences Inc.July 2025 Patterns & Reliable Volume Spike Alerts - Newser
Reversal Traders Monitor Ensysce Biosciences Inc. for Entry getLinesFromResByArray error: size == 0 - thegnnews.com
Real time alert setup for Ensysce Biosciences Inc. performance2025 Dividend Review & Technical Entry and Exit Alerts - Newser
Ensysce Biosciences Inc Stock (ENSC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):